Delcath Systems (DCTH) said it expects full-year 2025 revenue of $94 to $98 million.
Analysts surveyed by FactSet expect $94.1 million.
Delcath Systems also said it plans to enter into a Medicaid national drug rebate agreement with the Centers for Medicare and Medicaid Services to provide Medicaid rebates and 340B discounts to eligible entities, starting Q3.
Delcath Systems shares were more than 8% higher in premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.